STERIS PLC (STE) Shares Bought by World Asset Management Inc
World Asset Management Inc increased its position in shares of STERIS PLC (NYSE:STE) by 29.4% during the second quarter, Holdings Channel reports. The firm owned 5,407 shares of the medical equipment provider’s stock after buying an additional 1,230 shares during the period. World Asset Management Inc’s holdings in STERIS PLC were worth $441,000 as of its most recent filing with the SEC.
A number of other large investors also recently made changes to their positions in the stock. Investment Counselors of Maryland LLC raised its stake in shares of STERIS PLC by 28.7% in the first quarter. Investment Counselors of Maryland LLC now owns 2,640 shares of the medical equipment provider’s stock worth $183,000 after buying an additional 588 shares during the period. Aureus Asset Management LLC bought a new stake in shares of STERIS PLC during the first quarter worth about $245,000. CENTRAL TRUST Co raised its stake in shares of STERIS PLC by 1.3% in the first quarter. CENTRAL TRUST Co now owns 3,670 shares of the medical equipment provider’s stock worth $255,000 after buying an additional 47 shares during the period. Bbva Compass Bancshares Inc. raised its stake in shares of STERIS PLC by 9.2% in the first quarter. Bbva Compass Bancshares Inc. now owns 3,664 shares of the medical equipment provider’s stock worth $255,000 after buying an additional 308 shares during the period. Finally, Diversified Trust Co raised its stake in shares of STERIS PLC by 7.8% in the first quarter. Diversified Trust Co now owns 3,816 shares of the medical equipment provider’s stock worth $265,000 after buying an additional 275 shares during the period. 91.80% of the stock is owned by institutional investors and hedge funds.
STERIS PLC (NYSE:STE) opened at 84.94 on Friday. The company has a market capitalization of $7.24 billion, a P/E ratio of 60.76 and a beta of 1.33. The stock’s 50 day moving average price is $82.58 and its 200-day moving average price is $75.07. STERIS PLC has a 52-week low of $63.80 and a 52-week high of $87.49.
STERIS PLC (NYSE:STE) last posted its quarterly earnings results on Tuesday, August 8th. The medical equipment provider reported $0.85 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.80 by $0.05. The company had revenue of $608 million for the quarter, compared to analyst estimates of $597.66 million. STERIS PLC had a return on equity of 11.39% and a net margin of 4.63%. STERIS PLC’s revenue for the quarter was down 4.8% compared to the same quarter last year. During the same quarter last year, the company earned $0.79 EPS. Analysts predict that STERIS PLC will post $4.06 earnings per share for the current fiscal year.
The business also recently declared a quarterly dividend, which will be paid on Thursday, September 28th. Shareholders of record on Tuesday, August 29th will be given a $0.31 dividend. The ex-dividend date of this dividend is Friday, August 25th. This represents a $1.24 dividend on an annualized basis and a yield of 1.46%. This is a positive change from STERIS PLC’s previous quarterly dividend of $0.28. STERIS PLC’s dividend payout ratio (DPR) is currently 80.00%.
WARNING: “STERIS PLC (STE) Shares Bought by World Asset Management Inc” was originally reported by Daily Political and is owned by of Daily Political. If you are viewing this news story on another website, it was stolen and republished in violation of US & international copyright & trademark laws. The correct version of this news story can be accessed at https://www.dailypolitical.com/2017/08/12/steris-plc-ste-shares-bought-by-world-asset-management-inc.html.
A number of equities research analysts have issued reports on STE shares. BidaskClub lowered shares of STERIS PLC from a “strong-buy” rating to a “buy” rating in a report on Monday, July 31st. Zacks Investment Research raised shares of STERIS PLC from a “hold” rating to a “buy” rating and set a $92.00 price objective for the company in a report on Tuesday, July 11th. Wellington Shields lowered shares of STERIS PLC from a “gradually accumulate” rating to a “hold” rating in a report on Monday, June 5th. Raymond James Financial, Inc. increased their price objective on shares of STERIS PLC from $90.00 to $95.00 and gave the company an “outperform” rating in a report on Wednesday. Finally, KeyCorp raised shares of STERIS PLC from a “sector weight” rating to an “overweight” rating and set a $89.00 price objective for the company in a report on Wednesday, May 3rd. Two analysts have rated the stock with a hold rating and five have issued a buy rating to the company’s stock. The company presently has an average rating of “Buy” and an average target price of $86.75.
In other news, CEO Walter M. Rosebrough, Jr. sold 10,000 shares of the stock in a transaction dated Friday, June 2nd. The stock was sold at an average price of $80.05, for a total value of $800,500.00. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, Director Mohsen Sohi sold 2,744 shares of the stock in a transaction dated Wednesday, August 9th. The shares were sold at an average price of $85.98, for a total value of $235,929.12. Following the completion of the transaction, the director now owns 21,816 shares in the company, valued at approximately $1,875,739.68. The disclosure for this sale can be found here. Insiders sold a total of 33,084 shares of company stock worth $2,668,633 in the last ninety days. 2.55% of the stock is owned by corporate insiders.
About STERIS PLC
STERIS plc provides infection prevention and other procedural products and services. The Company operates through four segments: Healthcare Products, which offers infection prevention and procedural solutions for healthcare providers, including capital equipment and related maintenance, and installation services, as well as consumables; Healthcare Specialty Services, which provides a range of specialty services for healthcare providers, including hospital sterilization services, instrument and scope repairs, and linen management; Life Sciences, which offers capital equipment and consumable products, and equipment maintenance and specialty services for pharmaceutical manufacturers and research facilities, and Applied Sterilization Technologies, which offers contract sterilization and laboratory services for medical device and pharmaceutical customers and others.
Want to see what other hedge funds are holding STE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for STERIS PLC (NYSE:STE).
Receive News & Ratings for STERIS PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for STERIS PLC and related companies with MarketBeat.com's FREE daily email newsletter.